Immunotherapy has been one of the most promising advancements in cancer treatment. However, consistency in immunotherapy treatment effectiveness remains a formidable challenge. Now, Cancer Center at Illinois member Kun Wang, Binbin Wang, a post-doctoral researcher at the National Cancer Institute, and Robert Saddawi-Konefka, a physician-scientist at MD Anderson Cancer Center (formerly at UCSD) are taking the guesswork out of cancer treatments through a predictive model for determining immunotherapy treatment effectiveness.
This article was originally published on MedicalXpress.com
